|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4985 | (2006.01) |
| A61K 31/506 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/4985 | (2013.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 17/00 | (2018.01) |
| (11) | Number of the document | 4028007 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20771628.3 |
| Date of filing the European patent application | 2020-09-08 | |
| (97) | Date of publication of the European application | 2022-07-20 |
| (45) | Date of publication and mention of the grant of the patent | 2025-03-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2020/058333 |
| Date | 2020-09-08 |
| (87) | Number | WO 2021/048736 |
| Date | 2021-03-18 |
| (30) | Number | Date | Country code |
| 201962899133 P | 2019-09-11 | US |
| (72) |
FENSOME, Andrew , US
GERSTENBERGER, Brian Stephen , US
OWEN, Dafydd Rhys , US
|
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (54) | TREATMENT OF HIDRADENITIS SUPPURATIVA WITH A JAK INHIBITOR |
| TREATMENT OF HIDRADENITIS SUPPURATIVA WITH A JAK INHIBITOR |